Yoshimura, Satoshi
Panetta, John C.
Hu, Jianzhong https://orcid.org/0000-0002-7548-5802
Li, Lie
Gocho, Yoshihiro
Du, Guoqing
Umezawa, Akihiro
Karol, Seth E. https://orcid.org/0000-0001-8113-8180
Pui, Ching-Hon https://orcid.org/0000-0003-0303-5658
Mullighan, Charles G. https://orcid.org/0000-0002-1871-1850
Konopleva, Marina https://orcid.org/0000-0002-9347-2212
Stock, Wendy
Teachey, David T. https://orcid.org/0000-0001-7373-8987
Jain, Nitin
Yang, Jun J. https://orcid.org/0000-0002-0770-9659
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA264837, U01CA264610, P30CA21765, R01CA264837)
U.S. Department of Health & Human Services | National Institutes of Health
Takeda Pharmaceuticals U.S.A.
U.S. Department of Health & Human Services | National Institutes of Health
Leukemia and Lymphoma Society (6665-23)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 15 November 2022
Revised: 4 April 2023
Accepted: 6 April 2023
First Online: 19 April 2023
Competing interests
: This work was partly supported by Takeda Pharmaceutical Company. JH is a current employee of Amgen Inc.